Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Other Accumulated Expenses (2017 - 2024)

Historic Other Accumulated Expenses for Solid Biosciences (SLDB) over the last 7 years, with Q1 2024 value amounting to $92000.0.

  • Solid Biosciences' Other Accumulated Expenses rose 6727.27% to $92000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $92000.0, marking a year-over-year increase of 6727.27%. This contributed to the annual value of $24000.0 for FY2023, which is 7142.86% up from last year.
  • Per Solid Biosciences' latest filing, its Other Accumulated Expenses stood at $92000.0 for Q1 2024, which was up 6727.27% from $24000.0 recorded in Q4 2023.
  • In the past 5 years, Solid Biosciences' Other Accumulated Expenses ranged from a high of $162000.0 in Q3 2023 and a low of $14000.0 during Q4 2022
  • For the 4-year period, Solid Biosciences' Other Accumulated Expenses averaged around $74250.0, with its median value being $67000.0 (2021).
  • Data for Solid Biosciences' Other Accumulated Expenses shows a peak YoY increase of 40869.57% (in 2023) and a maximum YoY decrease of 6333.33% (in 2023) over the last 5 years.
  • Quarter analysis of 4 years shows Solid Biosciences' Other Accumulated Expenses stood at $35000.0 in 2021, then tumbled by 60.0% to $14000.0 in 2022, then skyrocketed by 71.43% to $24000.0 in 2023, then skyrocketed by 283.33% to $92000.0 in 2024.
  • Its Other Accumulated Expenses stands at $92000.0 for Q1 2024, versus $24000.0 for Q4 2023 and $162000.0 for Q3 2023.